Expression and immunogenicity of secreted forms of bovine ephemeral fever virus glycoproteins applied to subunit vaccine development
Open Access
- 18 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 131 (3) , 1123-1135
Abstract
Aims Vaccines for bovine ephemeral fever virus (BEFV) are available but are difficult to produce, expensive, or suffer from genetic instability. Therefore, we designed constructs encoding C‐terminally truncated forms (transmembrane anchoring region deleted) of glycoproteins G and GNS such that they were secreted from the cell into the media to achieve high‐level antigen expression, correct glycosylation pattern, and enable further simple purification with the V5 epitope tag. Methods and Results In this study, synthetic biology was employed to create membrane‐bound and secreted forms of G and GNS glycoprotein. Mammalian cell culture was employed as an antigen expression platform, and the secreted forms of G and GNS protein were easily purified from media by using a highly effective, single‐step method. The V5 epitope tag was genetically fused to the C‐termini of the proteins, enabling detection of the antigen through immunoblotting and immunomicroscopy. Our data demonstrated that the C‐terminally truncated form of the G glycoprotein was efficiently secreted from cells into the cell media. Moreover, the immunogenicity was confirmed in mice test. Conclusions The immuno‐dot blots showed that the truncated G glycoprotein was present in the total cell extract, and was clearly secreted into the media, consistent with the western blotting data and live‐cell images. Our strategy presented the expression of secreted, epitope‐tagged, forms of the BEFV glycoproteins such that appropriately glycosylated forms of BEFV G protein was secreted from the BHK‐21 cells. This indicates that high‐level expression of secreted G glycoprotein is a feasible strategy for large‐scale production of vaccines and improving vaccine efficacy. Significance and Impact of the Study The antigen expression strategy designed in this study can produce high‐quality recombinant protein and reduce the amount of antigen used in the vaccine.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST‐106‐2911‐I‐020‐501, MOST‐107‐2313‐B‐020‐011‐MY3)
- Biotechnology and Biological Sciences Research Council (BB/P025080/1)
This publication has 30 references indexed in Scilit:
- Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applicationsBMC Biotechnology, 2013
- Phylogenetic relationships of the glycoprotein gene of bovine ephemeral fever virus isolated from mainland China, Taiwan, Japan, Turkey, Israel and AustraliaVirology Journal, 2012
- Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein GScience, 2007
- E unum pluribus: multiple proteins from a self-processing polyproteinTrends in Biotechnology, 2006
- Targeting of Proteins Derived from Self‐Processing Polyproteins Containing Multiple Signal SequencesTraffic, 2004
- Epidemiology of bovine ephemeral fever virus infection in TaiwanMicrobiological Research, 1998
- Effective vaccination of cattle using the virion G protein of bovine ephemeral fever virus as an antigenVaccine, 1994
- The genome of bovine ephemeral fever rhabdovirus contains two related glycoprotein genesVirology, 1992
- Studies on the pathogenesis of bovine ephemeral fever in sentinel cattle. I. Virology and serologyVeterinary Microbiology, 1985
- Bovine ephemeral fever virus in cell culture and miceArchives of Virology, 1972